Document Detail

Glucocorticoids: effects on prostaglandin release, cyclic AMP levels and glycosaminoglycan synthesis in fibroblast tissue cultures.
MedLine Citation:
PMID:  189229     Owner:  NLM     Status:  MEDLINE    
Glucocorticoids (GCs) reduced cyclic AMP levels and inhibited glycosaminoglycan (GAG) synthesis in secondary embryonic mouse fibroblast cultures, when cells were incubated for short periods (30 min). The order of potency was dexamethasone greater than prednisolone greater than hydrocortisone. The effect was more marked, when cyclic AMP levels and GAG synthesis were increased by addition of PGE1. Glucocorticoids exerted no longer an inhibitory effect on cyclic AMP and GAG synthesis in cultures pretreated for 48 h with the steroids. Addition of PGE1 caused a stronger rise in cyclic AMP and GAG synthesis than in controls without GC-preincubation. This enhancement was even more pronounced, when PGE1 was added together with the GCs. The reversal of the inhibitory effect of the GCs into a potentiating effect following preincubation correlated to a reducation of endogenous PGE formation in the cultures. Short-term treatment with GCs did not reduce endogenous PGE levels, but prolonged incubation markedly decreased PGE levels. PGE formation recovered following addition of fresh medium after the 48 h incubation with the steroids, but the amount of PGE formed remained significantly lower than in untreated cultures. Non-glucocorticoid steroid hormones did not decrease PGE levels. The results indicate that the apparent loss of inhibitory activity of GCs on cyclic AMP and GAG synthesis observed after prolonged incubation may result from a reduction of endogenous PGE formation which renders the cells more sensitive to the stimulatory effect of exogenous PGE1.
H D Peters; B A Peskar; P S Schönhöfer
Related Documents :
25085519 - Susceptibility of calves to porcine circovirus-2 (pcv2).
2435609 - Investigations on the role of camp in regulating resorption of the tail fin from tadpol...
223359 - Early increase of cyclic adenosine monophosphate level induced by erythropoietin on rab...
8394829 - The effect of cyclic amp analogues and glucagon on cholesteryl ester synthesis and hydr...
7508389 - Cyclic amp regulation of messenger rna level of the stimulatory gtp-binding protein gs ...
10915219 - Somatostatin receptor gene expression and inhibitory effects of octreotide on primary c...
3102369 - Characterization of vascular relaxant factor released from cultured endothelial cells.
15348469 - Tissue engineering of dermal substitutes based on porous pegt/pbt copolymer scaffolds: ...
10213149 - Group i and ii metabotropic glutamate receptor expression in cultured rat spinal cord a...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Naunyn-Schmiedeberg's archives of pharmacology     Volume:  296     ISSN:  0028-1298     ISO Abbreviation:  Naunyn Schmiedebergs Arch. Pharmacol.     Publication Date:  1977 Jan 
Date Detail:
Created Date:  1977-03-31     Completed Date:  1977-03-31     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  0326264     Medline TA:  Naunyn Schmiedebergs Arch Pharmacol     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  131-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cells, Cultured
Cyclic AMP / metabolism*
Dexamethasone / pharmacology
Fibroblasts / drug effects,  metabolism
Glucocorticoids / pharmacology*
Glycosaminoglycans / biosynthesis*
Hydrocortisone / pharmacology
Prednisolone / pharmacology
Prostaglandins E / metabolism*,  pharmacology
Time Factors
Reg. No./Substance:
0/Glucocorticoids; 0/Glycosaminoglycans; 0/Prostaglandins E; 50-02-2/Dexamethasone; 50-23-7/Hydrocortisone; 50-24-8/Prednisolone; 60-92-4/Cyclic AMP

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  On the mechanism of the decrease in cerebellar cyclic GMP content elicited by opiate receptor agonis...
Next Document:  Further evidence for the involvement of cAMP in central blood pressure regulation.